Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


Sophion and Scottish Biomedical announce ion channel cell line collaboration

Press Release

San Francisco, CA (September 9, 2008). Sophion Bioscience and Scottish Biomedical announced today at the Ion Channel Targets conference that they have signed an agreement regarding ion channel cell lines. The agreement will give Sophion and Scottish Biomedical the right to provide cell lines optimized for the QPatch, Sophion’s automated patch clamp systems for the ion channel drug discovery and safety pharmacology.

“With this agreement with Sophion, we acquire a larger exposure to the market with our high quality ion channel cell lines,” said Morag Nelson, Business Development Manager at Scottish Biomedical, and she continues, “The combination of our multisubunit cell lines and Sophion’s ability to optimize them for QPatch experiments is a very promising collaboration.”

Dr. Morten Sunesen, Sophion’s Director of Customer Relations, added, “In line with our strategy of providing complete solutions for automated patch clamp, Sophion has further expanded its collaboration with an internationally leading ion channel cell line supplier. We are convinced that the pharmaceutical industry will benefit greatly from this agreement with Scottish Biomedical.”

In the near future Sophion’s QPatch 16 and QPatch HT automated patch clamp systems can be upgraded to allow for screening of cell clones and selection of the best cell clone for propagation. This feature is expected to further improve the quality of cell lines used for ion channel drug discovery and safety pharmacology – and eventually result in more and better drugs – faster.

About Sophion Bioscience
Sophion Bioscience, a leader in the automated patch clamp field, helps drug discovery companies make more and better drugs, faster. Sophion’s sole focus is to provide advanced products and integrated solutions for automated patch clamping Sophion’s QPatch 16 and QPatch HT (48-channels) provide high-quality patch clamp data on a truly industrial basis. Only the QPatch has an integrated cell preparation and QPlate exchange facilities enabling several hours of unattended operation. The unique microfluidic flow channel system implemented in the QPlates enables fast liquid exchange around each cell and provides the option to test multiple compounds or increasing concentrations on the same cell.

Sophion Bioscience A/S Sophion Bioscience Inc.
Baltorpvej 154 675 US Highway One
DK-2750 Ballerup North Brunswick, NJ 08902
Denmark USA
Phone: +45 44 60 88 00 Phone: +1 732 745 0221

About Scottish Biomedical
Established in 1994, Scottish Biomedical is a private, pre-clinical drug discovery service organisation located on the West of Scotland Science Park in Glasgow, Scotland. Scottish Biomedical’s drug discovery business integrates ethical tissue acquisition, molecular biology, protein technology, high-throughput screening, cell biology, medicinal chemistry and pharmacology to identify and validate novel drug targets and discover and optimise lead compounds. By combining their expertise in cell systems biology with medicinal chemistry, Scottish Biomedical has established many successful drug discovery collaborations with pharmaceutical/biotech clients around the world.

For further information please contact: Morten Sunesen, Ph.D., Director, Customer
Relations, Sophion Bioscience A/S, e-mail: or telephone: +45-
4460-8866 or Dr Morag Nelson, Ion Channel Business Development Manager,
Scottish Biomedical, email: or telephone +44
141 587 6100.

Publisher Contact Information:

Sophion Bioscience A/S

Company profile of Sophion Bioscience A/S
Past press releases of Sophion Bioscience A/S.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
May 30€15.0MBiopharmaceuticals
May 28€15.0MDiagnostics
May 28€1.3MInternet services
May 25€1.0MOther Software
May 20€1.6MMedical devices
May 20€3.7MDatabase

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Mar 31
the fit allocates chf 100'000 to comppair technologies

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.